Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**H3 histone pseudogene 6** (H3P6) is classified as a pseudogene, which means it is a gene sequence similar to a functional gene but lacks the ability to encode a functional protein. Pseudogenes arise due to mutations, gene duplications, or retrotranspositions that disrupt normal gene function. They are not considered functional targets for drugs, do not have established roles in biological processes or diseases, and are not therapeutically actionable. There is no evidence that H3P6 plays a regulatory or structural role, nor is it listed as a therapeutic target or biomarker in current biomedical literature[3].\n\nAssessment: This entry does not correspond to a functional target molecule or receptor (such as canonical histone H3 variants like H3.1, H3.2, or H3.3), and therefore, the entry "H3 histone pseudogene 6" is not relevant for therapeutic targeting or drug interaction studies[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone pseudogene 6 (H3P6).